• Explore /
  • Poster
  • / A phase 1b/2 umbrella study of investigational immune and targeted combination therapies as first-line therapy for patients with advanced renal cell carcinoma (RCC).

A phase 1b/2 umbrella study of investigational immune and targeted combination therapies as first-line therapy for patients with advanced renal cell carcinoma (RCC).

Abstract Poster

Authors

Elizabeth Plimack

Elizabeth R. Plimack

Fox Chase Cancer Center, Philadelphia, PA

Elizabeth R. Plimack , Hans J. Hammers , Toni K. Choueiri , Brian I. Rini , Robert J. Motzer , Leah Suttner , Rodolfo F. Perini , Jaqueline Willemann Rogerio , Laurence Albiges

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Kidney and Bladder

Track

Genitourinary Cancer—Kidney and Bladder

Sub Track

Kidney Cancer

Clinical Trial Registration Number

NCT04626479

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS4594)

DOI

10.1200/JCO.2021.39.15_suppl.TPS4594

Abstract #

TPS4594

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Robert J. Motzer

First Author: Ken Kato

First Author: Toni K. Choueiri

First Author: Lorenza Rimassa